Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Efficacy of GLP-1 receptor agonists on obesity and metabolic profile in patients with inflammatory bowel disease: a systematic review and meta-analysis
Buying this item online saves you from the frustration of visiting stores in person
When to contact your GP or diabetes team : Persistent vomiting preventing fluid intake Severe abdominal pain, especially if radiating to the back (possible pancreatitis) Right upper abdominal pain, fever or jaundice (possible gallbladder problems) Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained hypoglycaemia if on combination therapy New or worsening visual symptoms (especially if you have diabetic retinopathy) Allergic reactions (rash, swelling, breathing difficulties) Most patients tolerate GLP-1 medications well once past the initial adjustment period
rs1169299 and rs10466245 were also related to diabetes in DIAGRAM and HDL-cholesterol in GLGC respectively but did not reach genome-wide significance
Education and pre-treatment photography are crucial for managing expectations
